SC144 is primarily used in research and development, particularly in the study of cancer and related diseases. It is known for its role as a gp130 inhibitor, which makes it valuable in investigating signaling pathways involved in tumor growth and progression. Researchers utilize SC144 to explore its potential in suppressing cancer cell proliferation and inducing apoptosis, especially in cases where interleukin-6 (IL-6) and gp130 signaling are implicated. Its application extends to preclinical studies aimed at understanding its efficacy and mechanisms in various cancer models, potentially paving the way for novel therapeutic strategies.